�
Male reproductive system, prostate cancer is the most common malignancy, the incidence increased with age, mainly in patients 60 to 80 years old. Incidence rate of 14.3 in the United States and Europe - 23/10 million, cancer mortality in men ranked second, behind lung cancer. The incidence of prostate cancer before the lower, but the acceleration of the aging population, an increase of 10/10 million in recent years, jumping to the first male genitourinary cancer, lung cancer death rate has been higher than as a serious threat to the health of our older men important diseases.
menshealthknowledge.com
Every man's prostate problems may occur, especially after over 50 years. Early symptoms are not obvious, but the performance in the "night to urinate," more often, urine is reduced, urinary wait, etc., did not arouse enough attention to the patient, thus bringing to an early diagnosis difficult. Once there is a clear clinical symptoms, often already in advanced disease, poor prognosis. Advanced prostate cancer, mainly for the lower urinary tract obstructive symptoms, or hematuria and urinary retention, the most prominent symptom is pain, bone metastasis, the pelvic area or lumbosacral pain. From: http://menshealthknowledge.com
Traditional therapies can not prevent cancer metastasis and recurrence menshealthknowledge.com
Radical surgery is the only way to cure prostate cancer treatment, but only for early prostate cancer. Even so, it can not prevent cancer metastasis and recurrence, must tie in with radiotherapy and chemotherapy.
The relatively advanced computer simulations of radiation is the result after adaptive radiotherapy, to improve a certain therapeutic effect, but it also brings many complications, patients are often difficult to tolerate, while expensive, all under non-ordinary people.
Chemotherapy drugs often "non-clear", "regardless of the enemy" in killing tumor cells, but also destruction of the body's normal cells, a huge toxic effects and adverse reactions such as nausea, vomiting, loss of appetite, abdominal pain, diarrhea, and sore, sore throat, etc. menshealthknowledge.com
U.S. study found that a fourth anti-cancer therapy
From: http://menshealthknowledge.com
Therefore, how these cells from the immune and the root causes of cancer to start, to prevent the spread of cancer and metastasis, increased survival time in patients with advanced, scientists around the world has been the direction of cancer treatment, cancer treatment is the fundamental way . In 2008, the United States Temple University, Robert A Weinberg, Ph.D., and Stanford University, Dr. Dietmar W Siemann together cancer scientists in the field, from the rapid development of cytology and immunology to find a breakthrough, developed CLS autologous cell therapy, is an internationally recognized hopefully completely eliminate tumor cells of the fourth Dah Sing technology therapy.
From: http://menshealthknowledge.com
They found in the body's immune system, there are two special cells to fight against the cancer cell function: a dendritic cell is like a "radar" that can take the initiative to search for, identify cancer cells; with cells induced killer cell function as "missiles" that can accurately kill tumor cells, without any damage to normal tissue, to effectively kill the tumor but also to enhance the body's immune system. However, the body's normal levels of these two little cells, CLS technology breakthrough is the tremendous success isolated from human peripheral blood cells both by experiment and specialized value-added and activated GMP training, and then reinfusion to the patient body. From: http://menshealthknowledge.com
CLS immune therapy to improve 5-year survival rate nearly doubled From: http://menshealthknowledge.com
In the medical profession, the cure rate of cancer there is a crucial indicator called the five-year survival rate refers to the after treatment, another five-year period found no clinically visible metastases, tumor lesions, it is considered clinical cure. CLS therapy into clinical treatment in the United States, the well-known cancer specialist, Dr. Yamazaki did a group on the treatment and traditional treatment CLS comparisons. Studies have shown that: use of U.S. cancer patients treatment CLS 3-year survival rate was 72%, 33% unused; 5-year survival rate was 67%, 22% unused. Have made another person happy results. menshealthknowledge.com
Order for Chinese patients receiving simultaneous treatment CLS international frontier in 2009, the Second Hospital of Armed Police enormous amount of money from the U.S. introduction of the overall treatment CLS-compliant GMP standard laboratory established tumor biological treatment center, and sent officers to train abroad , the most common cell culture from the member to the authority of the immune experts, doctors, master high academic qualifications 50 percent, with experience in clinical and emergency ambulance 92%, to ensure the aspects of treatment that every detail on the CLS and the United States therapy to keep pace. menshealthknowledge.com
1000 that a number of patient outcomes: CLS therapy for their extended life, improved quality of life, to achieve significant results. Believe that before long, the history of high mortality of prostate cancer will be rewritten.
